Dergiler / Neurological sciences and neurophysiology (Online) / 2019 / Cilt: 36 - Sayı: 4

Interleukin-23 concentrations of NREM-AHI greater than REM-AHI versus REM-AHI greater than NREM- AHI in obstructive sleep apnea syndrome

Sayfa
198–201
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Taking the AHIREM val-ue into consideration along with the average AHI value seems to be important for treatment modalities.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Although the presence of a systemic inflammatory response is known in obstructive sleep apnea syndrome (OSAS), there have not been adequate investigations on the association of such a response with the predominance of apneas either in rapid eye movement (REM) or in the non-REM (NREM) phase.
📊
Temel Bulgular & Veri:In this study, we compared interleukin-23 (IL-23) concentrations, a marker of sys-temic inflammatory process, in individuals with sleep apnea syndrome, whose apneas where predominant in the REM or NREM phase.
💡
Sonuç & Katkı:Taking the AHIREM val-ue into consideration along with the average AHI value seems to be important for treatment modalities.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: Although the presence of a systemic inflammatory response is known in obstructive sleep apnea syndrome (OSAS), there have not been adequate investigations on the association of such a response with the predominance of apneas either in rapid eye movement (REM) or in the non-REM (NREM) phase. In this study, we compared interleukin-23 (IL-23) concentrations, a marker of sys-temic inflammatory process, in individuals with sleep apnea syndrome, whose apneas where predominant in the REM or NREM phase. Methods: Fifty-four patients aged over 18 years who were diagnosed as having OSAS based on polysomnography were includ-ed in the study. The apnea-hypopnea index (AHI) was used to divide patients into groups of AHIREM>AHINREM and AHINREM>AHIREM. In the blood samples drawn from the patients, IL-23 concentrations were measured using enzyme-linked immunosorbent assay. Results: The study included patients with OSAS aged 28-65 years, of whom 29 were AHIREM>AHINREM and 25 were AHINREM>AHIREM. The AHIREM>AHINREM OSAS group had no sex-based variance (14 males, 15 females), but the AHINREM>AHIREM group was substantial-ly composed of males (21 males, 4 females). The average AHI of the AHINREM>AHIREM group (43.34±21.40) was significantly higher than in the AHIREM>AHINREM group (26.79±17.32). IL-23 concentrations were higher in patients with AHIREM>AHINREM sleep apnea (225.38±77.29) compared patients with AHINREM>AHIREM sleep apnea (183.68±78.49). Conclusion: In AHIREM>AHINREM sleep apnea, the systemic inflammatory response may be more dramatic. Taking the AHIREM val-ue into consideration along with the average AHI value seems to be important for treatment modalities.

🔖

Bu Makaleye Atıf Yap

ÜNAL, Y., ÖZTÜRK, D. A., SERTOĞLU, E., Saruhan, E., YILMAZ, N., KUTLU, G. (2019). Interleukin-23 concentrations of NREM-AHI greater than REM-AHI versus REM-AHI greater than NREM- AHI in obstructive sleep apnea syndrome. Neurological sciences and neurophysiology (Online), Cilt: 36 - Sayı: 4, 198–201. https://ajindex.com/articles/290575

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Lim YH, Choi J, Kim KR, et al. Sex-specific characteristics of an-thropometry in patients with obstructive sleep apnea: neck cir-cumference and waist-hip ratio. Ann Otol Rhinol Laryngol 2014
  2. [CrossRef] 2. Can M, Uygur F, Tanrıverdi H, Acıkgoz B, Alper B, Guven B. Effect of continuous positive airway pressure (CPAP) therapy on IL-23 in patients with obstructive sleep apnea. Immunol Res 2016
  3. [CrossRef] 3. Liu Y, Su C, Liu R, et al. NREM-AHI greater than REM-AHI versus REM-AHI greater than NREM-AHI in patients with obstructive sleep apnea: clinical and polysomnographic features. Sleep Breath 2011
  4. [CrossRef] 4. Mokhlesi B, Finn LA, Hagen EW, et al. Obstructive sleep apnea during REM sleep and hypertension results of the Wisconsin Sleep Cohort. Am J Respir Crit Care Med 2014
  5. [CrossRef] 5. Huang YS, Guilleminault C, Hwang FM, et al. Inflammatory cyto-kines in pediatric obstructive sleep apnea. Medicine (Baltimore) 2016
  6. e4944. [CrossRef] 6. Nadeem R, Molnar J, Madbouly EM, et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 2013
  7. [CrossRef] 7. Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic in-flammation. Nat Rev Drug Discov 2012
  8. [CrossRef] 8. McSharry DG, Saboisky JP, Deyoung P, et al. Physiological mech-anisms of upper airway hypotonia during REM sleep. Sleep 2014
  9. [CrossRef] 9. Mokhlesi B. REM-related obstructive sleep apnea: to treat or not to treat? J Clin Sleep Med 2012
  10. [CrossRef] 10. Kasai T, Bradley TD. Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. J Am Coll Cardi-ol 2011
  11. [CrossRef] 11. Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fab-bian F. Circadian rhythms and cardiovascular health. Sleep Med Rev 2012
  12. [CrossRef] 12. Berry RB, Brooks R, Gamaldo CE, et al. For the American Acade-my of Sleep Medicine. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical speci-fications [version 2.4] Darien, IL: American Academy of Sleep Medicine
  13. Arnaud C, Dematteis M, Pepin JL, Baguet JP, Lévy P. Obstructive sleep apnea, immuno-inflammation, and atherosclerosis. Semin Immunopathol 2009
  14. [CrossRef] 14. McNicholas WT. Obstructive sleep apnea and inflammation. Prog Cardiovasc Dis 2009
  15. [CrossRef] 15. Bouloukaki I, Mermigkis C, Tzana